J clin oncol 2005 23 6549-55

Author: rquf

August undefined, 2024

WebThe toxic effects of high-dose chemotherapy were primarily myelosuppression, mucositis, nausea, vomiting, dehydration, peripheral neuropathy, and otologic abnormalities. 8 There … WebThe Journal of Clinical Oncology is a peer-reviewed medical journal published 3 times a month by the Lippincott Williams & Wilkins. It covers research on all aspects of clinical …

Current Management of Refractory Germ Cell Tumors and Future …

WebAug 17, 2024 · J Clin Oncol. 2005 Dec 20. 23(36):9290-4. [QxMD MEDLINE Link] . Kondagunta GV, Bacik J, Donadio A, Bajorin D, Marion S, Sheinfeld J. Combination of paclitaxel, ifosfamide, and cisplatin is an... mf 135 headlight assembly

Phase II multicenter study of the epidermal growth factor …

WebJan 10, 2024 · Relapse After Early-Stage, Favorable Hodgkin Lymphoma: Disease Characteristics and Outcomes With Conventional or High-Dose Chemotherapy. … WebAug 9, 2024 · 42. Kondagunta GV, Bacik J, Donadio A, Bajorin D, Marion S, Sheinfeld J, et al. Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. J Clin Oncol (2005) 23(27):6549–55. doi: 10.1200/JCO.2005.19.638. PubMed Abstract CrossRef Full Text Google Scholar WebJan 29, 2014 · J Clin Oncol. 2005. 23:6549-55. Ronnen EA, Kondagunta GV, Bacik J, et al. Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapy. J Clin … mf 1450 garden tractor

American Journal of Clinical Oncology - Wikipedia

Salvage treatment for testicular cancer with standard- or

WebMar 5, 2014 · We did this phase 3 randomised controlled trial (EORTC 62012) at 38 hospitals in ten countries. We included patients with locally advanced, unresectable, or metastatic high-grade soft-tissue sarcoma, age 18–60 years with a WHO performance status of 0 or 1. WebApr 8, 2024 · 55. Headley JA, Ownby KK, John Lauri D. The effect of seated exercise on fatigue and quality of life in women with advanced breast cancer. Oncol Nurs Forum 2004; 31(5): 977–983. Crossref. PubMed. ... J Clin Oncol 2005; 23(4): 899–909. Crossref. PubMed. ISI. Google Scholar. 59. mf 158 multipowerWebJan 1, 2009 · Request PDF On Jan 1, 2009, J.S. Parker and others published J Clin Oncol. Find, read and cite all the research you need on ResearchGate how to bypass napco zone alarm

"WebIntroduction. In China and all around the world, lung cancer remains the most common cause of death in cancer patients. 1 Of all lung cancers, non-small cell lung cancer (NSCLC), as a subclass, accounts for about 80–85% of the total incidence. 2 Adenocarcinoma is currently the predominant histological subtype of NSCLC. 3,4 The reported average 5-year … " - J clin oncol 2005 23 6549-55

J clin oncol 2005 23 6549-55

Optimal therapy for patients with hepatocellular carcinoma and ...

WebOct 1, 2005 · J Clin Oncol 23: 6549-6555 Home Pharmacology Chemistry Pharmaceuticals Paclitaxel Kondagunta GV, Bacik J, Donadio A, Bajorin D, Marion S, Sheinfeld J, Bosl GJ, Motzer RJCombination of... WebIntroduction. Multiple myeloma is a hematological malignancy characterized by neoplastic proliferation of clonal plasma cells. 1 Several landmark advances have been made in the …

Did you know?

WebJ Clin Oncol. 2005 Sep 20;23(27):6549-55. link to original article contains dosing details in manuscript PubMed; Kurobe M, Kawai K, Oikawa T, Ichioka D, Kandori S, Takaoka E, Kojima T, Joraku A, Suetomi T, Miyazaki J, Nishiyama H. Paclitaxel, ifosfamide, and cisplatin (TIP) as salvage and consolidation chemotherapy for advanced germ cell tumor. ... WebOct 24, 2024 · J Clin Oncol. 1998;16(7):2500-4. Kondagunta GV et al. Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. J Clin Oncol. 2005;23(27):6549-55.

WebMay 28, 2024 · Introduction. The US Food and Drug Administration (FDA) approves cancer drugs based on (1) overall survival (OS) or patient reported outcomes, (2) progression-free survival, ie, the time until cancer recurs or worsens, or (3) response rate (RR), ie, the percent of patients experiencing tumor shrinkage. 1,2 Response rate and complete response rate … WebMay 23, 2024 · J Clin Oncol. 2005;23: 6549-6555. Link, Google Scholar: 17. Nichols CR, Tricot G, Williams SD, et al. Dose-intensive chemotherapy in refractory germ cell cancer—a …

WebApr 27, 2024 · We systematically analyzed germ cell therapy trials with the goal of providing evidence for the efficacy of HDCT in the treatment of GCC. Our goal was to identify patient characteristics and... WebJ Clin Oncol 23:6549-6555. © 2005 by American Society of Clinical Oncology INTRODUCTION Between 70% and 80% of patients with ad-vanced, metastatic germ cell …

WebThis invention concerns methods of treating a patient diagnosed with glioblastoma comprising administering to said patient a therapy comprising an effective amount of an anti-VEGF antibody and a chemotherapeutic.

WebSep 21, 2016 · Journal of Clinical Oncology > List of Issues > Volume 23, Issue 27 > Genitourinary Cancer OPTIONS & TOOLS Combination of Paclitaxel, Ifosfamide, and Cisplatin Is an Effective Second-Line Therapy for Patients With Relapsed Testicular Germ Cell Tumors G. Varuni Kondagunta , Jennifer Bacik , Alessia Donadio , Dean Bajorin , … mf1538cWebJul 27, 2009 · J Clin Oncol. 2005; 23 (abstr).: 624s Google Scholar Definitive estimates are now available for all endpoints; median follow-up for all patients was 22·5 months (range 0·9–125·1) and for those still alive at the final analysis was 69·3 months (6·2–125·1). how to bypass nashville tn and get to i-24WebMar 30, 2024 · J Clin Oncol. 2008; 26:848–55. [Google Scholar] 12. ... J Clin Oncol. 2005; 23:190–6. [Google Scholar] 13. Booth CM, Eisenhauer EA. Progression-free survival: meaningful or simply measurable? J Clin Oncol. 2012; 30:1030–3. [Google Scholar] 14. Gajra A, Klepin HD, Feng T, et al. Predictors of chemotherapy dose reduction at first cycle in ... how to bypass my laptop passwordWebYou need to enable JavaScript to run this app. DocGuide. You need to enable JavaScript to run this app. how to bypass my computer passwordWebSearch worldwide, life-sciences literature Search. Advanced Search Coronavirus articles and preprints Search examples: "breast cancer" Smith J how to bypass mykey volume limitWebApr 20, 2005 · 10.1200/JCO.2005.09.050 Abstract Purpose: This is the first study in which the NK(1)-receptor antagonist, aprepitant (APR), was evaluated for the prevention of chemotherapy-induced nausea and vomiting (CINV) with moderately emetogenic chemotherapy. Patients and methods: how to bypass my iphone passcodeWebJ Clin Oncol. 2005;23(19):4338–4346. 23. Villa E, Ferretti I, Grottola A, et al. Hormonal therapy with megestrol in inoperable hepatocellular carcinoma characterized by variant oestrogen receptors. ... Lancet Oncol. 2013;14(1):55–63. 38. The ASCO Post. FDA expands approved use of regorafenib for hepatocellular carcinoma. 2024 Apr 27 ... mf1624-55 - 55w co2 laser engraver